Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Solange Peters

Showing results (61-70 of 362) with videos related to

Pageof 37
Sort By:
Journal of the International AIDS Society|November 14, 2014
Investigating barriers in HIV-testing oncology patients. The IBITOP study: phase ILaurent Merz, Solange Peters, Stefan Zimmermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2022
Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel StrategiesAntonio Passaro, Julie Brahmer, Scott Antonia, et al.
Journal for Immunotherapy of Cancer|July 24, 2021
Neutrophils in the era of immune checkpoint blockadeJulien Faget, Solange Peters, Xavier Quantin, et al.
Journal for Immunotherapy of Cancer|July 20, 2022
Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospectsSolange Peters, Luis Paz-Ares, Roy S Herbst, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2015
BRAF Alterations as Therapeutic Targets in Non-Small-Cell Lung CancerTu Nguyen-Ngoc, Hasna Bouchaab, Alex A Adjei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 11, 2017
RANKL Signaling Sustains Primary Tumor Growth in Genetically Engineered Mouse Models of Lung AdenocarcinomaJulien Faget, Caroline Contat, Nadine Zangger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2025
Neoadjuvant or Perioperative Chemoimmunotherapy Treatment in Patients with Resectable NSCLC: Still an Open Question. Comments on Marinelli et al. J Thorac Oncol. 2025;20:285-295Urania Dafni, Zoi Tsourti, Aikaterini Vervita, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2013
Treatment and detection of ALK-rearranged NSCLCSolange Peters, Miquel Taron, Lukas Bubendorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Trimodality therapy for locally advanced non-small-cell lung cancer: a curative approachRoger Stupp, Daniel Betticher, Hans-Beat Ris, et al.
Journal for Immunotherapy of Cancer|January 26, 2022
Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapiesOlivier Michielin, Aly-Khan Lalani, Caroline Robert, et al.
Pageof 37

Showing results (61-70 of 362) with videos related to

Sort By:
Pageof 37
Journal of the International AIDS Society|November 14, 2014
Investigating barriers in HIV-testing oncology patients. The IBITOP study: phase ILaurent Merz, Solange Peters, Stefan Zimmermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2022
Managing Resistance to Immune Checkpoint Inhibitors in Lung Cancer: Treatment and Novel StrategiesAntonio Passaro, Julie Brahmer, Scott Antonia, et al.
Journal for Immunotherapy of Cancer|July 24, 2021
Neutrophils in the era of immune checkpoint blockadeJulien Faget, Solange Peters, Xavier Quantin, et al.
Journal for Immunotherapy of Cancer|July 20, 2022
Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospectsSolange Peters, Luis Paz-Ares, Roy S Herbst, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2015
BRAF Alterations as Therapeutic Targets in Non-Small-Cell Lung CancerTu Nguyen-Ngoc, Hasna Bouchaab, Alex A Adjei, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 11, 2017
RANKL Signaling Sustains Primary Tumor Growth in Genetically Engineered Mouse Models of Lung AdenocarcinomaJulien Faget, Caroline Contat, Nadine Zangger, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2025
Neoadjuvant or Perioperative Chemoimmunotherapy Treatment in Patients with Resectable NSCLC: Still an Open Question. Comments on Marinelli et al. J Thorac Oncol. 2025;20:285-295Urania Dafni, Zoi Tsourti, Aikaterini Vervita, et al.
Lung Cancer (Amsterdam, Netherlands)|June 18, 2013
Treatment and detection of ALK-rearranged NSCLCSolange Peters, Miquel Taron, Lukas Bubendorf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Trimodality therapy for locally advanced non-small-cell lung cancer: a curative approachRoger Stupp, Daniel Betticher, Hans-Beat Ris, et al.
Journal for Immunotherapy of Cancer|January 26, 2022
Defining unique clinical hallmarks for immune checkpoint inhibitor-based therapiesOlivier Michielin, Aly-Khan Lalani, Caroline Robert, et al.
Pageof 37